Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 6/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 9/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1908637 | 0.88 | AHCY (0.55) | AHCYADORA3ADORA1ADORA2A | |
| SCHEMBL26381988 | 0.86 | AHCY (0.57) | AHCYADORA3ADORA1ADORA2A | |
| SCHEMBL29501905 | 0.84 | AHCY (0.73) | AHCYADORA3ADORA1ADORA2A | |
| SCHEMBL447258 | 0.84 | AHCY (0.73) | AHCYADORA3ADORA1ADORA2A | |
| SCHEMBL19148493 | 0.83 | YTHDC1 (0.46) | ADORA3ADORA1ADORA2A | |
| SCHEMBL26381995 | 0.80 | AHCY (0.71) | AHCYADORA3 | |
| SCHEMBL13177712 | 0.77 | HTR2C (0.38) | AHCYADORA3ADORA1ADORA2A | |
| SCHEMBL8960194 | 0.76 | AHCY (0.56) | AHCYADORA3ADORA1ADORA2A | |
| SCHEMBL12050237 | 0.76 | AHCY (0.56) | AHCYADORA3ADORA1ADORA2A | |
| SCHEMBL26382100 | 0.74 | AHCY (0.71) | AHCY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230302003-A1 | COMPOSITIONS AND METHODS FOR TREATING A CORONAVIRUS INFECTION | ANTIRNA INCORPORATED | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230302003-A1 | COMPOSITIONS AND METHODS FOR TREATING A CORONAVIRUS INFECTION | AHCY, AHCYL1, BHMT | AHCY 1/4885ADORA3 931/4885ADORA1 700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.